Médecins pour Biopsie du foie à l'étranger — Page 3

Dr. Viola Fox is the Chief Physician at the Clinic for Oncology in Solingen. She is a leading expert in drug therapy for tumors in Germany and Europe. Dr. Fox holds a qualification in specialist genetics and conducts molecular biology research. She treats complex cases at a certified interdisciplinary cancer center.

• Member of the American Association for Cancer Research.
• Specializes in immunotherapy, targeted therapy, and molecular diagnostics.
• Treats hematological diseases, including lymphoma, leukemia, and myeloma.
• Works at Städtisches Klinikum Solingen, a clinic ranked among the top in Germany.

Le médecin est oncologue spécialisé dans le traitement des cancers du sein, du poumon et gastro-intestinaux. Actuellement, le médecin exerce à l'hôpital universitaire Istinye Liv.

Avec une carrière couvrant plusieurs institutions prestigieuses, le médecin a servi comme spécialiste en médecine interne à l'hôpital d'État de Malatya, médecin à la clinique d'oncologie d'Ankara et membre du département d'oncologie de l'hôpital régional de formation et de recherche d'Erzurum.

Le médecin est diplômé de la faculté de médecine de l'université de Selcuk et a obtenu le titre de professeur associé en 2016.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Le médecin est un oncologue médical de premier plan spécialisé dans le traitement du cancer par des thérapies ciblées moléculaires et la médecine personnalisée. Avec une vaste expérience, le médecin a servi de conseiller au ministère espagnol de la Santé et a dirigé l'Institut d'oncologie Vall d’Hebron.<\/p>

Le médecin a occupé des postes prestigieux, y compris Président de la Société Européenne d'Oncologie Médicale et Chef de l'Unité des Tumeurs Digestives et Endocriniennes à l'Hôpital Quirónsalud Barcelone. Le médecin est un chercheur prolifique avec plus de 70 articles publiés et a été reconnu par des récompenses telles que le Prix de Soins du Cancer en Cancer Gastro-intestinal par l'American Society of Clinical Oncology.<\/p>

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Mehmet Ali Gok is an Associate Professor of General Surgery at Medipol University Pendik Hospital. He specializes in laparoscopic hernia repair and metabolic surgery. Dr. Gok has authored over 20 national and international scientific articles on surgical outcomes. He practices at a hospital with 95.4 out of 96.4 healthcare quality points.

• Certified in robotic colorectal surgery and laparoscopic hernia techniques on cadavers.
• Received specialized training from the European Hernia Society in Dubai.
• Served as a former Chief Physician at Silopi State Hospital.
• Editor of several medical books on oncological, hernia, and minimal invasive surgery.

Expérience

Clinique de radiologie de l'hôpital Liman

Centre Médical de l'Académie

Centre Médical Anaclinique

Hôpital d'État de Kayseri

Clinique de radiologie universitaire Kayseri Erciyes

Centre médical privé Midiliv de Samsun

Hôpital Samsun Büyük Anadolu (2023)

Dr. Nihat Okcu is a gastroenterologist and gastrointestinal surgeon at Medipol University Pendik Hospital. He specializes in the treatment of complex digestive conditions and liver diseases. Dr. Okcu has published over 20 academic papers on gastric cancer and endoscopic diagnosis. He serves at a hospital with a 95.4% healthcare quality score.

• Performs laparoscopic anti-reflux surgery and small intestine resections.
• Expert in gastric polyps removal and duodenal polyp excision.
• Treats chronic conditions like cirrhosis, Crohn’s disease, and ulcerative colitis.
• Provides diagnostic gastroscopy with biopsy and ultrasound-guided procedures.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Le médecin est gynécologue spécialisé dans les opérations endoscopiques et laparoscopiques. Avec un accent sur les techniques chirurgicales peu invasives, le médecin est compétent pour réaliser des procédures avancées qui améliorent la récupération et les résultats des patients. Le médecin a une vaste expérience dans la gestion de cas gynécologiques complexes, utilisant des technologies de pointe pour fournir des soins optimaux.<\/p>

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Shady Mohammed El‑sebai is an interventional radiologist and diagnostic imaging consultant. He is the Consultant and Chief of Interventional Radiology at Sheaf El Orman Oncology Hospital (2021–present). He is also Chief of the Interventional Radiology Unit at the National Cancer Institute, Cairo University (2022–present). He has been a Lecturer in interventional radiology at the National Cancer Institute since 2018. Earlier posts include assistant lecturer and specialist, radiology resident, specialist at Khartoum Breast Care Centre, and specialist and consultant at Techno Scan.

Expertise includes CT‑ and US‑guided true‑cut biopsies and FNAC; transarterial chemoembolization for HCC and for liver, renal, and soft‑tissue tumors; percutaneous nephrostomy and ureteric stents; pigtail drainage; and RF or microwave ablation of hepatic, bone, lung, and thyroid lesions. He also performs PTD and biliary stents; uterine artery embolization; coiling for pelvic varicosities and varicocele; varicose vein ablation and sclerotherapy; and breast procedures (biopsy, markers, wire localization, Mammotome). He is skilled in US, CT, and MRI.

Le médecin est un mammologue très expérimenté, spécialisé dans la chirurgie mammaire. Avec un accent sur les techniques chirurgicales innovantes, le médecin dirige le département de chirurgie mammaire, garantissant des soins et des résultats de premier ordre pour les patients. Le médecin est reconnu pour ses contributions au traitement du cancer du sein et a publié de nombreux articles de recherche dans des revues médicales prestigieuses. Le médecin participe également à des essais cliniques visant à améliorer les thérapies contre le cancer du sein et a reçu de nombreux prix pour son excellence dans la pratique chirurgicale et les soins aux patients.<\/p>

Le médecin est un oncochirurgien très expérimenté, spécialisé dans les techniques chirurgicales avancées pour le traitement du cancer. Avec une expertise étendue dans le domaine, le médecin a contribué de manière significative au développement de protocoles chirurgicaux innovants visant à améliorer les résultats des patients. Le médecin est reconnu pour son engagement envers l'excellence clinique et a publié de nombreux articles de recherche dans des revues médicales prestigieuses. En tant que professeur, le médecin participe activement à la formation de la prochaine génération de chirurgiens, en soulignant l'importance de la précision et des soins centrés sur le patient en oncochirurgie.<\/p>